Edgewise Therapeutics, Inc. (EWTX)
44.22
-0.50
(-1.12%)
USD |
NASDAQ |
Aug 25, 16:00
44.22
0.00 (0.00%)
After-Hours: 19:59
Edgewise Therapeutics Shareholders Equity (Quarterly) : 448.08M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 448.08M |
| March 31, 2026 | 493.20M |
| December 31, 2025 | 522.26M |
| September 30, 2025 | 558.65M |
| June 30, 2025 | 589.07M |
| March 31, 2025 | 429.72M |
| December 31, 2024 | 459.22M |
| September 30, 2024 | 488.88M |
| June 30, 2024 | 510.47M |
| March 31, 2024 | 534.94M |
| December 31, 2023 | 318.83M |
| September 30, 2023 | 290.43M |
| Date | Value |
|---|---|
| June 30, 2023 | 311.46M |
| March 31, 2023 | 328.84M |
| December 31, 2022 | 346.72M |
| September 30, 2022 | 361.40M |
| June 30, 2022 | 246.36M |
| March 31, 2022 | 260.36M |
| December 31, 2021 | 274.38M |
| September 30, 2021 | 285.40M |
| June 30, 2021 | 296.75M |
| March 31, 2021 | 306.39M |
| December 31, 2020 | -33.42M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 1.044M |
| CNBX Pharmaceuticals, Inc. | -2.660M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 562.20M |
| Fulcrum Therapeutics, Inc. | 310.70M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 479.69M |
| Total Liabilities (Quarterly) | 31.61M |
| Debt to Equity Ratio | 0.008 |
| Current Ratio | 16.24 |
| Net Debt Paydown Yield | 0.00% |